Register Now: IKRIS Breast Cancer Awareness Run 2022

Tag Archives: relapsed or refractory advance renal cell carcinoma

U.S. Food and Drug Administration Approves Tivozanib for Relapsed or Refractory Advanced RCC

According to a press release from AVEO Oncology, “On March 10’th, 2021, the FDA has granted approval to tivozanib (Fotivda), […]

March 12, 2021